Evidence map›Paper›PMID 41989440›Full record

ArticleNeuropsychology2026

Repeated presentation of a word list in a consistent order increases differences in total words recalled between those with and without Alzheimer's disease.

Evan Grandoit, Seo-Eun Choi, Laura A Rabin, Roos J Jutten, Dan Mungas, Melissa Lamar, Nancy S Foldi, Beth E Snitz, C Elizabeth Shaaban, Emily H Trittschuh and 8 more

Abstract read
In one paragraph

Article in Neuropsychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Evan GrandoitDepartment of Psychology, Northwestern University.ORCID 0000-0003-4926-6013
Seo-Eun ChoiDepartment of Psychiatry and Behavioral Sciences, University of Washington.
Laura A RabinDepartment of Psychology, Graduate Center, Brooklyn College, City University of New York.
Roos J JuttenMassachusetts General Hospital.
Dan MungasDepartment of Neurology, University of California, Davis.
Melissa LamarDepartment of Psychiatry and Behavioral Sciences, Rush Alzheimer's Disease Center, Rush University Medical Center.ORCID 0000-0001-6130-5543
Nancy S FoldiDepartment of Psychology, Graduate Center, Queens College, City University of New York.
Beth E SnitzDepartment of Neurology, University of Pittsburgh.
C Elizabeth ShaabanDepartment of Epidemiology, University of Pittsburgh.
Emily H TrittschuhDepartment of Psychiatry and Behavioral Sciences, University of Washington.
Richard N JonesDepartment of Psychiatry and Human Behavior, Brown University.
Douglas TommetDepartment of Psychiatry and Human Behavior, Brown University.
Shubhabrata MukherjeeDepartment of Medicine, University of Washington.
Phoebe ScollardDepartment of Medicine, University of Washington.
Michael L LeeDepartment of Medicine, University of Washington.
Brandon S KlinedinstDepartment of Medicine, University of Washington.
Chun WangCollege of Education, University of Washington.
Paul K CraneDepartment of Medicine, University of Washington.

Funding

Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergicsU19AG066567 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Dori E Rosenberg · 2021 to 2026
$80.4M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 1985 to 2019
$43.0M
Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical SyndromesU54NS115266 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2019 to 2023
$10.3M
Search for the Alzheimers GenesR01AG030653 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 2009 to 2019
$7.7M
Improving Cognitive Outcome Precision & Responsiveness with Modern PsychometricsR01AG029672 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K · 2007 to 2021
$7.0M
National Institutes of Health; National Institute of General Medical SciencesNational Science FoundationNHGRI NIH HHS U01 HG006375NIA NIH HHS K01 AG071849NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG072978NIA NIH HHS P50 AG005133NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG029672NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG030653NIA NIH HHS R01 AG041718NIA NIH HHS U01 AG006781NIA NIH HHS U01 AG032984NIA NIH HHS U19 AG066567NIGMS NIH HHS SC3 GM122662NIH HHSNINDS NIH HHS T32 NS047987NINDS NIH HHS U01 NS086659NINDS NIH HHS U54 NS115266
6 · The paper itself

Abstract

objectiveIndividuals with Alzheimer's disease (AD) are known to have difficulty utilizing semantic strategy to remember items from a list, such as during word list recall tasks. However, it is unclear if presenting words in the same order as compared to shuffling across trials of a list-learning test confers an advantage in terms of word recall in individuals with AD.

methodTo address this issue, we leveraged data from 10,504 participants over five studies across four AD Research Centers that administered the Consortium to Establish a Registry for AD Word List Memory Test in either a standard sequence (shuffled words for each learning trial) or nonstandard sequence (unshuffled words in a consistent order for each learning trial).

resultsAfter controlling for gender, age, years of education, apolipoprotein E gene, Clinical Dementia Rating Global Score, and composite test scores for executive functioning and language comprehension, we found that differences in word recall performance between participants with and without probable AD were larger when they were tested with the unshuffled versus standard shuffled version of the word list.

conclusionsWhen administered the unshuffled Consortium to Establish a Registry for AD Word List, participants without AD demonstrated a larger recall advantage compared to those with probable AD. This advantage was higher on Trial 3 (β = 0.09) compared to Trial 2 (β = 0.04), suggesting that this advantage increases with multiple immediate repetitions. Using an unshuffled word list may enhance the ability to distinguish between individuals along the AD continuum. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Indexed as

Alzheimer DiseaseMental RecallVerbal LearningAgedAged, 80 and overFemaleHumansMaleNeuropsychological Tests

Identifiers

PMID41989440
PMCPMC13155764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.